Surgical strategy for the treatment of medullary thyroid carcinoma

Annals of Surgery

Volumn 230, Issue 5, 1999, Pages 697-707

  Fleming, Jason B ^a   Lee, Jeffrey E ^a   Bouvet, Michael ^a   Schultz, Pamela N ^a   Sherman, Steven I ^a   Sellin, Rena V ^a   Friend, Keith E ^a   Burgess, M Andrew ^a   Cote, Gilbert J ^a   Gagel, Robert F ^a   Evans, Douglas B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; CALCITONIN; CARCINOMA, MEDULLARY; CHILD; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0033498338     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199911000-00013     Document Type: Article

References (25)

1. Evans DB, Burgess MA, Goepfert H, Gagel RF. Medullary thyroid cancer. In: Bardin CW, ed. Current therapy in endocrinology and metabolism, 6th ed. St. Louis: Mosby-Year Book; 1997:127-132.
2. Wohllk N, Cote G, Evans DB, et al. Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocrinol Metab Clin North Am 1996; 25:1-25.
3. Tisell LE, Dilley WG, Wells SA. Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels. Surgery 1996; 119:34-39.
4. Buhr HJ, Kallinowski F, Raue F, et al. Microsurgical neck dissection for metastasizing medullary thyroid carcinoma. Eur J Surg Oncol 1995; 21:195-197.
5. Dottorini ME, Assi A, Sironi M, et al. Multivariate analysis of patients with medullary thyroid carcinoma. Cancer 1996; 77:1556-1565.
6. Fuchshuber PR, Loree TR, Hicks WL Jr, et al. Medullary carcinoma of the thyroid: prognostic factors and treatment recommendations. Ann Surg Oncol 1998; 5:81-86.
7. Gimm O, Dralle H. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified? Surgery 1997; 122:1124-1130.
8. Kallinowski F, Buhr HJ, Meybier H, et al. Medullary carcinoma of the thyroid - therapeutic strategy derived from fifteen years of experience. Surgery 1993; 114:491-496.
9. Moley JF, Dilley WG, DeBenedetti MK. Improved results of cervical reoperation for medullary thyroid carcinoma. Ann Surg 1997; 225: 734-743.
10. Schroder S, Bocker W, Baisch H, et al. Prognostic factors in medullary thyroid carcinomas. Cancer 1988; 61:806-816.
11. van Heerden JA, Grant CS, Gharib H, et al. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 1990; 212:395-401.
12. Brierley J, Tsang R, Simpson WJ, et al. Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 1996; 6:305-310.
13. Saad MF, Ordonez NG, Rashid RK, et al. Medullary carcinoma of the thyroid. Medicine 1984; 63:319-341.
14. Samaan NA, Schultz PN, Hickey RC. Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. J Clin Endocrinol Metab 1988; 67:801-805.
15. Doppman J. Discussion of Tung WS, Vesely TM, Moley JF. Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer. Surgery 1995; 118:1029.
16. Tisell LE, Hansson G, Jansson S, et al. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986; 99:60-66.
17. Dralle H, Damm I, Scheumann GFW, et al. Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 1994; 14:112-121.
18. Cady B. In discussion of: Gimm O, Dralle H. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified? Surgery 1997; 122:1130-1131.
19. Norton JA, Doppman JL, Brennan MF. Localization and resection of clinically inapparent medullary carcinoma of the thyroid. Surgery 1980; 87:616-622.
20. Frank-Raue K, Raue F, Buhr HJ, et al. Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid 1992; 2: 113-117.
21. Abdelmoumene N, Schlumberger M, Gardet P, et al. Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Br J Cancer 1994; 69:1141-1144.
22. Simpson WJ, Palmer JA, Rosen IB, et al. Management of medullary carcinoma of the thyroid. Am J Surg 1982; 144:420-422.
23. Gharib H, McConahey WM, Tiegs RD, et al. Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients. Mayo Clin Proc 1992; 67:934-940.
24. Marzano LA, Porcelli A, Biondi B, et al. Surgical management and follow-up of medullary thyroid carcinoma. J Surg Oncol 1995; 59: 162-168.
25. Udelsman R, Lakatos E, Ladenson P. Optimal surgery for papillary thyroid carcinoma. World J Surg 1996; 20:88-93.